Skip to Content

Publications Search - Abstract View

Title: Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study.
Authors: Hofmann JN,  Baccarelli A,  Schwartz K,  Davis FG,  Ruterbusch JJ,  Hoxha M,  McCarthy BJ,  Savage SA,  Wacholder S,  Rothman N,  Graubard BI,  Colt JS,  Chow WH,  Purdue MP
Journal: Br J Cancer
Date: 2011 Nov 22
Branches: BB, CGB, OEEB
PubMed ID: 22033273
PMC ID: PMC3242602
Abstract: BACKGROUND: There are few known risk factors for renal cell carcinoma (RCC). Two small hospital-based case-control studies suggested an association between short blood telomere length (TL) and increased RCC risk. METHODS: We conducted a large population-based case-control study in two metropolitan regions of the United States comparing relative TL in DNA derived from peripheral blood samples from 891 RCC cases and 894 controls. Odds ratios and 95% confidence intervals were estimated using unconditional logistic regression in both unadjusted and adjusted models. RESULTS: Median TL was 0.85 for both cases and controls (P=0.40), and no differences in RCC risk by quartiles of TL were observed. Results of analyses stratified by age, sex, race, tumour stage, and time from RCC diagnosis to blood collection were similarly null. In multivariate analyses among controls, increasing age and history of hypertension were associated with shorter TL (P<0.001 and P=0.07, respectively), and African Americans had longer TL than Caucasians (P<0.001). CONCLUSION: These data do not support the hypothesis that blood TL is associated with RCC. This population-based case-control study is, to our knowledge, the largest investigation to date of TL and RCC.